Home
Dashboard
Bookmarks
Portfolios
ExplorerFunds
Equities
Library
Insights
Pinindices
MobileApp Store
Android

Biopharma

Next 60 MidCap Biotech FirmsWith market capitalizations between $2bn and $10bn, the performance of the midcap biotech selection has gained momentum
Next 60 MidCap Biotech Firms
  • 118.3%
  • 61
Medical Advancement, Health and Wellbeing ETFsTaking a long view on transformative trends in healthcare and wellbeing
Medical Advancement, Health and Wellbeing ETFs
  • 40.4%
  • 7
Next 60 Small-Cap BiotechSelection of small market cap biotech firms, below $2 billion
Next 60 Small-Cap Biotech
  • 83.4%
  • 60
Biotech Movers - a January '23 SurpriseReversal of the negative 2022 trend of biotech firms has been notable - the industry remains volatile but investments could be rewarding
Biotech Movers - a January '23 Surprise
  • 37.1%
  • 17